Since GLP-1 is used for medical weight management, some patients may have coverage options, while others may explore self-pay pricing
Landmark trials show semaglutide reduces body weight by 10% to 16% over 68 weeks of continuous treatment
Healthcare professionals should emphasise that sustainable metabolic health depends on overall dietary quality, appropriate macronutrient balance, regular physical activity, and adherence to evidence-based guidelines rather than reliance on individual food products with unsubstantiated health claims
doi: 10.3390/ijms23073822
FDA Approves New Option to Treat Heavy Menstrual Bleeding Associated with Fibroids in Women | FDA (2020)
The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast